tiprankstipranks
Advertisement
Advertisement
Harrow price target lowered to $65 from $74 at B. Riley
PremiumThe FlyHarrow price target lowered to $65 from $74 at B. Riley
30d ago
Harrow price target lowered to $65 from $74 at B. Riley
Premium
The Fly
Harrow price target lowered to $65 from $74 at B. Riley
30d ago
Harrow Health Expands Senior Notes Offering for Growth
Premium
Company Announcements
Harrow Health Expands Senior Notes Offering for Growth
1M ago
Harrow Health: Evolving Into an Integrated Ophthalmic Platform With Clinical Catalysts and Commercial Upside Supporting a Buy Rating
PremiumRatingsHarrow Health: Evolving Into an Integrated Ophthalmic Platform With Clinical Catalysts and Commercial Upside Supporting a Buy Rating
2M ago
Harrow Health Updates Investor Presentation via Regulation FD Filing
Premium
Company Announcements
Harrow Health Updates Investor Presentation via Regulation FD Filing
2M ago
Harrow Health Projects Robust Growth After Strong 2025
Premium
Company Announcements
Harrow Health Projects Robust Growth After Strong 2025
2M ago
Harrow announces U.S. FDA cleared an IND application for trial of Triesence
PremiumThe FlyHarrow announces U.S. FDA cleared an IND application for trial of Triesence
2M ago
Closing Bell Movers: MongoDB down over 20% after soft Q1 guidance
Premium
The Fly
Closing Bell Movers: MongoDB down over 20% after soft Q1 guidance
2M ago
Harrow Health Posts Record 2025 Results, Sets 2026 Outlook
Premium
Company Announcements
Harrow Health Posts Record 2025 Results, Sets 2026 Outlook
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100